Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated May 26, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Passage Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 25
| |||||||
Aligos Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 23
| |||||||
Tempest Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Passage Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 26
| |||||||
Tempest Therapeutics, Inc.
| 2.12M |
$2.36 | $4,999,999.84 |
∞
| 2.12M |
Apr 29
| |||||||
Tempest Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Gritstone Bio, Inc.
| -444.62K |
—
|
—
| -32.99% | 903.09K |
Aug 25
|
Scheduled
| ||||||
Tempest Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Millendo Therapeutics, Inc.
| 2.18M |
—
|
—
|
∞
| 2.18M |
Jun 25
| |||||||
Millendo Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Aligos Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 17
| |||||||
Aligos Therapeutics, Inc.
| -483.75K |
—
|
—
| -24.86% | 1.46M |
Jun 11
|
Scheduled
| ||||||
Passage Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 27
| |||||||
Adverum Biotechnologies, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 12
| |||||||
Aligos Therapeutics, Inc.
| -483.75K |
—
|
—
| -19.91% | 1.95M |
Apr 26
|
Scheduled
| ||||||
Gritstone Oncology, Inc.
| 1.35M |
$3.71 | $5,000,000.39 |
∞
| 1.35M |
Dec 30
| |||||||
Adverum Biotechnologies, Inc.
| 12.78K |
—
|
—
| +211.67% | 18.82K |
Dec 14
| |||||||
Aligos Therapeutics, Inc.
| 3.29M |
$15.00 |
—
|
∞
| 3.29M |
Oct 20
| |||||||
Aligos Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Adverum Biotechnologies, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 23
| |||||||
Gritstone Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 18
| |||||||
Passage Bio, Inc.
| 4.96M |
$18.00 |
—
|
∞
| 4.96M |
Mar 3
| |||||||
Passage Bio, Inc.
| 4.96M |
$18.00 |
—
|
∞
| 4.96M |
Mar 3
| |||||||
Passage Bio, Inc.
|
0
|
—
|
—
|
—
|
0
|
Feb 27
| |||||||
Passage Bio, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Passage Bio, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Adverum Biotechnologies, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 31
| |||||||
Gritstone Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 19
| |||||||
Gritstone Oncology, Inc.
| 3.1M |
—
|
—
|
∞
| 3.1M |
Oct 2
| |||||||
Gritstone Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Crispr Therapeutics Ag
|
0
|
—
|
—
|
—
|
0
|
Jun 15
| |||||||
Adverum Biotechnologies, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 31
| |||||||
Crispr Therapeutics Ag
| -44.00K |
$57.99 | -$2,551,440.00 | -6.43% | 640.01K |
May 15
| |||||||
Crispr Therapeutics Ag
| -121.36K |
$50.86 | -$6,115,872.59 | -4.26% | 2.73M |
May 7 - May 8
|
Scheduled
| ||||||
Crispr Therapeutics Ag
| -30.57K |
$50.28 | -$1,537,137.92 | -2.03% | 1.48M |
Apr 30
|
Scheduled
| ||||||
Crispr Therapeutics Ag
| -222.26K |
$50.08 | -$11,136,437.01 | -6.84% | 3.03M |
Apr 26 - Apr 27
|
Scheduled
| ||||||
Crispr Therapeutics Ag
| -22.84K |
$50.90 | -$1,164,655.40 | -1.30% | 1.73M |
Apr 24
|
Scheduled
| ||||||
Crispr Therapeutics Ag
| -599.67K |
$50.83 | -$5,168,901.34 | -13.00% | 4.01M |
Apr 20 - Apr 23
|
Scheduled
| ||||||
Crispr Therapeutics Ag
| -3.06K |
$20.29 | -$62,070.47 | -38.15% | 4.96K |
Dec 22
|
Scheduled
| ||||||
Crispr Therapeutics Ag
| -1.90K |
$20.21 | -$38,405.85 | -19.16% | 8.02K |
Nov 24 - Nov 27
|
Scheduled
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.